Poland· PL-100326253
FDGtomosil
A fludeoxyglucose (18f) product containing fludeoxyglucosum (18f), registered in Poland by Narodowy Instytut Onkologii im. Marii Skłodowskiej Curie - Państwowy Instytut Badawczy. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fludeoxyglucose (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09IX04 (fludeoxyglucose (18f)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Fludeoxyglucose (18f) · ATC V09IX04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Fludeoxyglucosum (18F)
- Manufacturer
- Narodowy Instytut Onkologii im. Marii Skłodowskiej Curie - Państwowy Instytut Badawczy
- Country
- Poland (PL)
- ATC code
- V09IX04
- ATC class
- Fludeoxyglucose (18F)
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991191344
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
46 interactions on record for fludeoxyglucose (18f).
Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fludeoxyglucose (18f) · interactions on record
46 records
- 46 moderate
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Liquid paraffinA06AA01moderate
- BisacodylA06AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V09IX04
Fludeoxyglucose (18f), as other registers publish it.
- Czechia(18F)FDG-FRAlliance Medical RP Berlin GmbH, Berlin
- Germany[18f]-Fdg-Fzk Zag ZyklotronZag Zyklotron Ag
- Germany[18f]fdgEuro-Pet Gmbh
- Netherlands[18F]FDG Alliance Medical 300-3100 MBq/ml oplossing voor injectieAlliance Medical RP Berlin GmbH
- Germany[18f]fdg-LeUniversitaetsklinikum Leipzig Aoer
- Germany[18f]fludeoxyglucoseAlliance Medical Rp Berlin Gmbh
- Canada[F-18]-FLUDEOXYGLUCOSE (FDG) INJECTIONSYLVIA FEDORUK CANADIAN CENTRE FOR NUCLEAR INNOVATION
- Netherlands18F-FDG Hoboken 250 MBq/ml, oplossing voor injectieTheranostics Erasmus MC B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0d59c266-8aac-475f-993d-bd91de4fb4fc GET /v1/drugs/0d59c266-8aac-475f-993d-bd91de4fb4fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "550 MBq/ml",
"packaging": "05909991191344 ¦ Lz ¦ 104185\n1 fiol.",
"substance": "Fludeoxyglucosum (18F) 550 MBq na czas kalibracji",
"common_name": "Fludeoxyglucosum (18F)",
"pl_product_id": "100326253",
"pozwolenie_nr": "22068",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about fludeoxyglucose (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.